Baudax Bio Inc
OTC:BXRXQ
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Baudax Bio Inc
OTC:BXRXQ
|
US |
|
Abingdon Health PLC
LSE:ABDX
|
UK |
|
Taiba Investments Company SJSC
SAU:4090
|
SA |
|
Anritsu Corp
OTC:AITUF
|
JP |
|
K
|
Kiwibox.com Inc
OTC:KIWB
|
US |
|
J
|
Jiangsu NanFang Precision Co Ltd
SZSE:002553
|
CN |
|
Synchrony Financial
NYSE:SYF
|
US |
|
Koninklijke Ahold Delhaize NV
AEX:AD
|
NL |
|
Amman Mineral Internasional Tbk PT
IDX:AMMN
|
ID |
|
SBI Holdings Inc
TSE:8473
|
JP |
|
Shikibo Ltd
TSE:3109
|
JP |
|
Youdao Inc
NYSE:DAO
|
CN |
|
A
|
Aeon Kyushu Co Ltd
TSE:2653
|
JP |
|
T
|
TNG Investment and Trading JSC
VN:TNG
|
VN |
|
S
|
Sunsea AIoT Technology Co Ltd
SZSE:002313
|
CN |
|
National Medical Care Company JSC
SAU:4005
|
SA |
|
Bright Mountain Media Inc
OTC:BMTM
|
US |
|
Joy City Property Ltd
HKEX:207
|
HK |
|
W
|
Welcure Drugs and Pharmaceuticals Ltd
BSE:524661
|
IN |
|
G
|
Guangdong Yueyun Transportation Co Ltd
HKEX:3399
|
CN |
|
G
|
GR Properties Ltd
HKEX:108
|
HK |
|
Glory Ltd
TSE:6457
|
JP |
|
B
|
Bonlon Industries Ltd
BSE:543211
|
IN |
|
Playmates Toys Ltd
HKEX:869
|
HK |
Relative Value
There is not enough data to reliably calculate the relative value of BXRXQ.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
BXRXQ Competitors Multiples
Baudax Bio Inc Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Baudax Bio Inc
OTC:BXRXQ
|
44 USD | 0 | -0 | -0 | -0 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
856.7B USD | 13.1 | 41.5 | 28 | 29.9 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
566.8B USD | 6 | 21.1 | 14.7 | 18.1 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
243.3B CHF | 4 | 18.9 | 11.2 | 12.6 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
216.4B GBP | 4.9 | 28.3 | 15.7 | 22.2 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
282.6B USD | 4.3 | 15.5 | 9.6 | 11.7 | |
| CH |
|
Novartis AG
SIX:NOVN
|
222.2B CHF | 5.1 | 20.4 | 12.7 | 16.3 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.4 | 10.3 | 7.7 | 9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
153.4B USD | 2.5 | 19.7 | 7.6 | 10.1 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
115.7B USD | 2.4 | 16.4 | 7 | 8.6 |